IL179337A0 - Pharmaceutical compositions for the treatment of pruritus - Google Patents

Pharmaceutical compositions for the treatment of pruritus

Info

Publication number
IL179337A0
IL179337A0 IL179337A IL17933706A IL179337A0 IL 179337 A0 IL179337 A0 IL 179337A0 IL 179337 A IL179337 A IL 179337A IL 17933706 A IL17933706 A IL 17933706A IL 179337 A0 IL179337 A0 IL 179337A0
Authority
IL
Israel
Prior art keywords
pruritus
treatment
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL179337A
Other languages
English (en)
Original Assignee
Jonathan Burbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonathan Burbaum filed Critical Jonathan Burbaum
Publication of IL179337A0 publication Critical patent/IL179337A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL179337A 2004-06-03 2006-11-16 Pharmaceutical compositions for the treatment of pruritus IL179337A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57652704P 2004-06-03 2004-06-03
PCT/US2005/019738 WO2005117871A2 (fr) 2004-06-03 2005-06-03 Compostions pharmaceutiques pour le traitement d'un prurit

Publications (1)

Publication Number Publication Date
IL179337A0 true IL179337A0 (en) 2007-03-08

Family

ID=35463323

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179337A IL179337A0 (en) 2004-06-03 2006-11-16 Pharmaceutical compositions for the treatment of pruritus

Country Status (7)

Country Link
US (1) US20050272772A1 (fr)
EP (1) EP1763349A2 (fr)
JP (1) JP2008502603A (fr)
AU (1) AU2005249581A1 (fr)
CA (1) CA2566217A1 (fr)
IL (1) IL179337A0 (fr)
WO (1) WO2005117871A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
US9172611B2 (en) * 2006-09-01 2015-10-27 Spirent Communications, Inc. System and method for discovering assets and functional relationships in a network
US20090155325A1 (en) * 2007-12-14 2009-06-18 Kimberly-Clark Worldwide, Inc. Formulation and products for promoting skin cleanliness and health
ITFI20110241A1 (it) * 2011-11-03 2013-05-04 Lo Li Pharma Srl Formulazioni per migliorare la probabilità di fecondazione ed il numero di gravidanze
NZ708371A (en) * 2012-12-14 2020-05-29 Trevi Therapeutics Inc Methods for treating pruritus
US20140179727A1 (en) 2012-12-14 2014-06-26 Trevi Therapeutics, Inc. Methods for treating pruritus
DK3466930T3 (da) 2013-02-08 2022-09-05 Gen Mills Inc Fødevareprodukt med reduceret natriumindhold
MX2021000908A (es) 2018-07-23 2021-06-08 Trevi Therapeutics Inc Tratamiento de la tos cronica, la dificultad respiratoria y la disnea.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134166A (en) * 1988-12-02 1992-07-28 Genderm Corporation Method for treating nasal disorders and headaches
US5008289A (en) * 1988-12-02 1991-04-16 Galenpharma, Inc. Composition for treating nasal disorders and headaches
US4997853A (en) * 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US6248788B1 (en) * 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US5856361A (en) * 1996-04-23 1999-01-05 Medical Merchandising, Inc. Pain reliever and method of use
JP3211027B2 (ja) * 1998-11-13 2001-09-25 丸石製薬株式会社 カプサイシン含有外用剤
JP2001213772A (ja) * 2000-01-28 2001-08-07 Health Science Center:Kk 皮膚塗布剤組成物
US20020009491A1 (en) * 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues
US6495602B1 (en) * 2001-12-13 2002-12-17 Bradley Pharmaceuticals, Inc. Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
JP5148271B2 (ja) * 2004-06-02 2013-02-20 ニューロジズエックス，インコーポレーテッド 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物

Also Published As

Publication number Publication date
JP2008502603A (ja) 2008-01-31
CA2566217A1 (fr) 2005-12-15
US20050272772A1 (en) 2005-12-08
AU2005249581A1 (en) 2005-12-15
WO2005117871A2 (fr) 2005-12-15
WO2005117871A3 (fr) 2009-04-09
EP1763349A2 (fr) 2007-03-21

Similar Documents

Publication Publication Date Title
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
TWI369987B (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
IL186267A0 (en) New pharmaceutical compositions for treatment of thrombosis
EP2107909A4 (fr) Composes et compositions pharmaceutiques destines au traitement des troubles hepatiques
IL178775A0 (en) Pharmaceutical compositions for acute glucocorticoid therapy
PL1765391T3 (pl) Kompozycje bakteryjne do leczenia nowotworów
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
ZA200704915B (en) Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions
HK1163672A1 (en) Processes for the preparation of compounds
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
IL179337A0 (en) Pharmaceutical compositions for the treatment of pruritus
IL183930A0 (en) Use of cladribine for preparation of pharmaceutical compositions
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
IL177735A0 (en) Combined pharmaceutical composition for the inhibition of the decline of cognitive functions
PT2474528E (pt) Compostos antineoplásicos e composições farmacêuticas dos mesmos
HU0500145D0 (en) Composition for the treatment of oral diseases
ZA200609685B (en) Pharmaceutical compositions for acute glucocorticoid therapy
PL1687006T3 (pl) Kompozycje farmaceutyczne do leczenia zaburzeń czynności nerek
HU0500685D0 (en) Pharmaceutical composition for the treatment of psychosis
HUP0500947A2 (en) Composition for treatment of paradontosis
EP1948199A4 (fr) Compositions pharmaceutiques pour l'administration d'aptameres
HUP0401176A2 (en) Pharmaceutical composition having prpkinetic effect
HUP0500948A2 (en) Composition for treatment of diabeticus paradontosis
IL176303A0 (en) Pharmaceutical composition for the treatment of otomycosis